Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study
Condition(s):HFRS (Hemorrhagic Fever With Renal Syndrome)Last Updated:August 24, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):HFRS (Hemorrhagic Fever With Renal Syndrome)Last Updated:August 24, 2023Recruiting
Condition(s):Immune ThrombocytopeniaLast Updated:March 27, 2024Active, not recruiting
Condition(s):Dengue FeverLast Updated:September 29, 2011Completed
Condition(s):Pregnancy RelatedLast Updated:February 21, 2023Recruiting
Condition(s):HealthyLast Updated:September 13, 2011Completed
Condition(s):West Nile VirusLast Updated:February 7, 2011Completed
Condition(s):HealthyLast Updated:March 14, 2018Completed
Condition(s):Burn ShockLast Updated:November 15, 2022Completed
Condition(s):Primary Immunodeficiency Diseases (PID); Agammaglobulinemia; HypogammaglobulinemiaLast Updated:August 24, 2021Completed
Condition(s):Primary Immune Deficiency DisorderLast Updated:June 10, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.